New technique identifies SARS-CoV-2 in blood and other fluids with high sensitivity

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients.

Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says

Prime Medicine is considering developing cell therapies for autoimmune diseases and will likely look for a partner for cancer cell therapies, CEO Keith Gottesdiener said during

June 15, 2023

Life science VC Vertex Ventures HC raises $200M in new fund

Vertex Ventures HC is launching its largest fund yet, with $200 million and co-led by former pharma exec Christine Brennan. Vertex Ventures HC (VVHC) said

June 28, 2023

Hologic promotes Essex Mitchell to COO

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Name: Essex Mitchell New title: Chief Operating

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.